Verve Therapeutics Inc

-1.47 (-8.81%)
7:59:16 PM EDT: $15.50 +0.28 (+1.84%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)941.08M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.37 Million
Adjusted EPS-$0.77
See more estimates
10-Day MA$16.56
50-Day MA$20.14
200-Day MA$25.39
See more pivots

Verve Therapeutics Inc Stock, NASDAQ:VERV

201 Brookline Avenue, Suite 601, Boston, Massachusetts 02215
United States of America
Phone: +1.617.603.0070
Number of Employees: 204


Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular disease. The company was founded by Sekar Kathiresan, Kiran Musunuru, Keith J. Joung, Issi Rozen, Sekar Kathiresan, Burt A. Adelman, and Barry Ticho in 2018 and is headquartered in Boston, MA.